David's high conviction small cap list
About this video
David Lane from Ord Minnett comments on the updated analyst small cap conviction list, removing Electro Optic Systems (ASX:EOS) after a 40% surge since last year. Despite recent European contracts, David sees better opportunities elsewhere. He highlights Bubs Australia (ASX:BUB), focused on infant formula with a strong management team and upcoming FDA approvals.
David discusses the defensive nature of companies with ongoing revenue from banks and credit card providers like Cuscal (ASX:CCL). The company resembles the backend of Australia's payment system and has long-term growth potential. David forecasts 10% earnings growth annually over four years, finding it reasonably priced.
In healthcare, David has bullish forecasts for Regis Healthcare (ASX:REG), a beneficiary of governmental changes in aged care. The company boasts an average tenure of 2.6 years and a significant rise in earnings. His high-conviction list also includes Aussie Broadband (ASX:ABB), Brazilian rare earths (ASX:BRE), and other notable stocks.